Related Experiment Video
Updated: Jul 18, 2026

08:36
A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology
Published on: March 17, 2016
8.1K
Proteomic dissection of vanishing white matter pathogenesis
Jodie H K Man1,2, Parand Zarekiani3, Peter Mosen4,5
1Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Cellular and Molecular Life Sciences : CMLS
|May 24, 2024
Summary
Vanishing white matter (VWM) pathogenesis was studied in a mouse model, revealing region- and time-dependent protein changes. These findings offer insights into VWM progression and potential therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Vanishing white matter (VWM) is a severe leukodystrophy linked to eukaryotic translation initiation factor 2B variants.
- The precise mechanisms driving VWM pathogenesis remain incompletely understood.
- Investigating VWM pathogenesis requires robust models that recapitulate key aspects of the human disease.
Purpose of the Study:
- To investigate the molecular basis of VWM pathogenesis using the 2b5ho mouse model.
- To identify temporal and regional proteomic alterations in the VWM mouse brain.
- To compare mouse proteomic data with human VWM patient data to identify conserved disease mechanisms.
Main Methods:
- Proteomic analysis of cerebellum, corpus callosum, cortex, and brainstem in 2b5ho and wild-type mice at different time points.
- Temporal mapping of protein expression changes.
- Cross-referencing mouse proteomic data with existing VWM patient brain proteomic datasets.
Main Results:
- Proteomic dysregulation was observed in the cerebellum and cortex of 2b5ho mice before overt pathology.
- Corpus callosum proteome changes occurred after disease onset, while brainstem changes were transient.
- Significant overlap was found between proteomic alterations in the 2b5ho mouse model and VWM patients, suggesting conserved pathogenic pathways.
Conclusions:
- The 2b5ho mouse model partially replicates human VWM at the proteomic level.
- Proteomic alterations in VWM are region- and time-dependent.
- This study provides a valuable resource for understanding VWM pathogenesis and identifying potential therapeutic targets by highlighting early, late, and progression-driving molecular changes.

